Viking Therap(VKTX.US)

Last Updated 19:00:00 ET
longbridge loading

10 Health Care Stocks Whale Activity In Today's Session

benzinga_article·
US
QURE
-0.55%
US
VKTX
+3.13%
US
NVO
+1.19%
benzinga_article·
US
QURE
-0.55%
US
VKTX
+3.13%
US
NVO
+1.19%

Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026 | VKTX Stock News

StockTitan·
US
VKTX
+3.13%
StockTitan·
US
VKTX
+3.13%

Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026 | VKTX Stock News

StockTitan·
US
VKTX
+3.13%
US
FBT
+1.40%
US
XBI
+3.59%
StockTitan·
US
VKTX
+3.13%
US
FBT
+1.40%
US
XBI
+3.59%

Nash Maintains Buy on Viking Therapeutics, Keeps $107 Price Target Unchanged Amid Strong Cash Runway and Expanded VK2735 Study

Tip Ranks·
US
VKTX
+3.13%
US
FBT
+1.40%
US
BIB
+4.14%
Tip Ranks·
US
VKTX
+3.13%
US
FBT
+1.40%
US
BIB
+4.14%

Viking Therapeutics' (VKTX) "Buy" Rating Reaffirmed at BTIG Research

Market Beat·
US
VKTX
+3.13%
US
FBT
+1.40%
US
XBI
+3.59%
Market Beat·
US
VKTX
+3.13%
US
FBT
+1.40%
US
XBI
+3.59%

Stifel Nicolaus Remains a Buy on Viking Therapeutics (VKTX)

Tip Ranks·
US
VKTX
+3.13%
US
BBH
+0.52%
US
LABU
+10.85%
Tip Ranks·
US
VKTX
+3.13%
US
BBH
+0.52%
US
LABU
+10.85%

Viking Therap | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
VKTX
+3.13%
Earnings Watch·
US
VKTX
+3.13%
© 2026 Longbridge｜Disclaimer